Top Markets
Coin of the day
Pear Therapeutics, Inc. Pear Therapeutics, Inc.

Pear Therapeutics, Inc.

PEAR
株式のランク #40500
Pear Therapeutics, Inc. is a commercial-phase medical company focused on... Pear Therapeutics, Inc. is a commercial-phase medical company focused on inventing and distributing digital therapeutics. Its current offerings include reSET, which addresses substance use disorders involving alcohol, cannabis, cocaine, and stimulants; reSET-O, prescribed alongside buprenorphine for opioid use disorder; and Somryst, a digital solution for chronic insomnia. Beyond these marketed therapies, the company maintains a robust development pipeline of 14 prospective products. These investigational treatments span various therapeutic areas, encompassing psychiatry, neurology, and non-central nervous system conditions like gastrointestinal, oncological, and cardiovascular disorders. Founded in 2013, Pear Therapeutics, Inc. is headquartered in Boston, Massachusetts.
株価
$0.0048
最終同期: 2023-05-23
時価総額
$132.48K
変化(1日)
-20.00%
変化(1年)
0.00%
US
取引 Pear Therapeutics, Inc. (PEAR)

カテゴリー

Pear Therapeutics, Inc.(PEAR)の配当利回りの履歴
Pear Therapeutics, Inc.(銘柄コード: PEAR)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Pear Therapeutics, Inc.(PEAR)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)